Panacea Biotec Stock Surges Amid Strong Market Momentum and Increased Investor Participation
Panacea Biotec Ltd's stock reached an intraday high of Rs 513.65, hitting the upper circuit limit. The stock showed strong performance, outperforming its sector and demonstrating stable price action. Increased delivery volume indicates heightened investor participation, reflecting positive sentiment in the market.
Panacea Biotec Ltd, a small-cap player in the Pharmaceuticals & Drugs industry, has made headlines today as its stock hit the upper circuit limit, reaching an impressive intraday high of Rs 513.65. This marks a significant change of Rs 24.45, translating to a 5% increase from the previous trading session. The stock opened with a notable gain of 4.87%, reflecting strong market momentum.Throughout the trading day, Panacea Biotec demonstrated robust performance metrics, outperforming its sector by 6.06%. The stock traded within a narrow range of just Rs 0.65, indicating stable price action. With a total traded volume of approximately 0.12991 lakh shares and a turnover of Rs 0.67 crore, the liquidity appears sufficient for trading activities.
In terms of moving averages, the stock is currently positioned higher than the 20-day, 50-day, 100-day, and 200-day averages, although it remains below the 5-day moving average. Notably, delivery volume has increased by 6.75% compared to the 5-day average, suggesting rising investor participation.
Overall, Panacea Biotec's performance today highlights its strong market position and positive trading activity, reflecting a favorable sentiment among market participants.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
